Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 08, 2019

SELL
$20.52 - $26.45 $307,800 - $396,750
-15,000 Closed
0 $0
Q1 2019

May 06, 2019

BUY
$20.23 - $26.29 $303,450 - $394,350
15,000 New
15,000 $370,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.78B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Cidel Asset Management Inc Portfolio

Follow Cidel Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cidel Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cidel Asset Management Inc with notifications on news.